Author

Andrew David. Berti

Eugene Applebaum College of Pharmacy and Health SciencesORCID 0000-0001-5658-1973Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Arnold S. BayeriD· 1 shared Callan R. BleickiD· 1 shared Michael Joseph RybakiD· 1 shared Rita Richa· 1 shared Sean R. Van HeldeniD· 1 shared Susan M. LehmaniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Arnold S. BayerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Optimizing phage-antibiotic combinations: impact of administration order against daptomycin non-susceptible (DNS) MRSA clinical isolates

Callan R. Bleick, Sean R. Van Helden, Andrew David. Berti, Rita Richa, Susan M. Lehman, Arnold S. Bayer, Michael Joseph Rybak

This study evaluates phage-antibiotic combinations against DNS-MRSA strains, finding that simultaneous administration outperforms sequential regimens in ex-vivo models.

Antimicrobial Agents and Chemotherapy · Nov 18, 2025Peer-reviewedMicrobiology